{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T01:28:54Z","timestamp":1649208534991},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1989,3,1]],"date-time":"1989-03-01T00:00:00Z","timestamp":604713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[1989,3]]},"DOI":"10.1007\/bf02214110","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T01:48:55Z","timestamp":1128563335000},"page":"54-62","source":"Crossref","is-referenced-by-count":5,"title":["Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee"],"prefix":"10.1007","volume":"8","author":[{"given":"P. N.","family":"Platt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02214110_CR1","series-title":"series 11","volume-title":"Osteoarthritis prevalence in adults by age, sex, race and geographic area","author":"J. Roberts","year":"1966","unstructured":"Roberts, J., Burch, T.A. Osteoarthritis prevalence in adults by age, sex, race and geographic area. Washington, D.C.: U.S. Public Health Service Publication 1,000; series 11, No. 15, 1966."},{"key":"BF02214110_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bmj.286.6363.418","volume":"286","author":"D.L. Gardner","year":"1983","unstructured":"Gardner, D.L. The nature and causes of osteoarthritis. Br Med J 1983, 286, 418\u2013424.","journal-title":"Br Med J"},{"key":"BF02214110_CR3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.1982.tb04958.x","volume":"14","author":"D.L. Scott","year":"1982","unstructured":"Scott, D.L., Roden, S., Marshall, T., Kendall, M.J. Variations in responses to nonsteroidal anti-inflammatory drugs. Br J Clin Pharmacol 1982, 14, 691\u2013694.","journal-title":"Br J Clin Pharmacol"},{"key":"BF02214110_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF01965392","volume":"12","author":"R.R. Martel","year":"1982","unstructured":"Martel, R.R., Klicius, J. Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs. Agents Actions 1982, 12, 295\u2013297.","journal-title":"Agents Actions"},{"key":"BF02214110_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1139\/y76-037","volume":"54","author":"R.R. Martel","year":"1976","unstructured":"Martel, R.R., Klicius, J. Anti-inflammatory and analgesic properties of etodolic acid in rats. Can J Physiol Pharmacol 1976, 54, 245\u2013248.","journal-title":"Can J Physiol Pharmacol"},{"key":"BF02214110_CR6","first-page":"782","volume":"33","author":"M. Sanda","year":"1983","unstructured":"Sanda, M., Collins, S.H., Mahady, J., Huth, J., Krantz, K. Three-month multicenter study of etodolac (Ultradol\u00ae) in patients with osteoarthritis of the hip. Curr Ther Res 1983, 33, 782\u2013792.","journal-title":"Curr Ther Res"},{"key":"BF02214110_CR7","first-page":"1","volume":"2","author":"M.L. Koonce","year":"1984","unstructured":"Koonce, M.L., Levy, M.E. Long-term study of etodolac in the treatment of patients with osteoarthritis. Today's Ther Trends 1984, 2, 1\u20137.","journal-title":"Today's Ther Trends"},{"key":"BF02214110_CR8","first-page":"651","volume":"5","author":"S.Y. Andelman","year":"1983","unstructured":"Andelman, S.Y. Etodolac, aspirin, and placebo in patients with degenerative joint disease, a twelveweek study. Clin Ther 1983, 5, 651\u2013661.","journal-title":"Clin Ther"},{"key":"BF02214110_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/clpt.1988.75","volume":"43","author":"M. Kraml","year":"1987","unstructured":"Kraml, M., Hicks, D.R., McKean, M., Panagides, J., Furst, J. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis. Clin Pharmacol Ther 1987, 43, 571\u2013574.","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"BF02214110_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02214108","volume":"8","author":"Y. Henrotin","year":"1989","unstructured":"Henrotin, Y., Bassleer, C., Franchimont, P. Effects of etodolac on human chondrocytes cultivated in three dimensions. Clin Rheumatol 1989, 8, Suppl 1, 36\u201342.","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02214110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02214110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02214110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T16:14:44Z","timestamp":1557850484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02214110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":10,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1989,3]]}},"alternative-id":["BF02214110"],"URL":"https:\/\/doi.org\/10.1007\/bf02214110","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}